Enhanced nanoparticle delivery exploiting tumour-responsive formulations

Nanoparticles can be used as drug carriers, contrast agents and radiosensitisers for the treatment of cancer. Nanoparticles can either passively accumulate within tumour sites, or be conjugated with targeting ligands to actively enable tumour deposition. With respect to passive accumulation, particl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennie, Lindsey A., McCarthy, Helen O., Coulter, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276285/
https://www.ncbi.nlm.nih.gov/pubmed/30595759
http://dx.doi.org/10.1186/s12645-018-0044-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276285/
https://www.ncbi.nlm.nih.gov/pubmed/30595759
http://dx.doi.org/10.1186/s12645-018-0044-6

Ejemplares similares